Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.
Indian J Cancer
;
1996 Mar; 33(1): 17-20
Artículo
en Inglés
| IMSEAR
| ID: sea-50995
ABSTRACT
Ondansetron was used as an antiemetic along with dexamethasone during 16 cycles of highly or moderately ematogenic chemotherapy. There was major control in two cycles and complete control in the remaining 14. Side effects were minor and did not require discontinuation of the drug. This combination, therefore, appears to be safe and effective in preventing chemotherapy induced emesis.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Antagonistas de la Serotonina
/
Vómitos
/
Femenino
/
Humanos
/
Masculino
/
Dexametasona
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Receptores de Serotonina
/
Ondansetrón
/
Adulto
Idioma:
Inglés
Revista:
Indian J Cancer
Año:
1996
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS